Lakefront Biotherapeutics (LKFT) Intangibles (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Intangibles for 13 consecutive years, with $848913.9 the latest figure, recorded in Q1 2026.

• Quarterly Intangibles fell 99.52% year-over-year to $848913.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $848913.9 (down 99.52% YoY) and the FY2025 annual result came in at $964985.2, down 99.49% from the prior year.
• Intangibles fell to $848913.9 in Q1 2026 per LKFT's latest filing, from $964985.2 in the prior quarter.
• Over the last five years, Intangibles for LKFT reached as high as $201.1 million in Q4 2022 and fell as low as $848913.9 in Q1 2026.
• A 5-year average of $127.9 million and a median of $160.4 million in 2023 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles surged 194.06% — and 2026, when it plunged 99.52%.
• Year by year, Intangibles stood at $201.1 million in 2022, then decreased by 0.82% to $199.5 million in 2023, then fell by 5.95% to $187.6 million in 2024, then slumped by 99.49% to $964985.2 in 2025, then retreated by 12.03% to $848913.9 in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $848913.9, $964985.2, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.